(Q38180320)

30 August 2017

title

Molecular analysis of circulating tumour cells-biology and biomarkers (English)

1 reference

30 August 2017

0 references

5

1 reference

30 August 2017

Matthew G Krebs

1

0 references

Louise Carter

object named as

Louise Carter

3

0 references

Caroline Dive

object named as

Caroline Dive

6

0 references

author name string

Robert L Metcalf

2

1 reference

30 August 2017

Ged Brady

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

21 January 2014

1 reference

Nature Reviews Clinical Oncology

30 August 2017

published in

1 reference

30 August 2017

volume

11

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

129-144

1 reference

Personalized medicine in oncology: the future is now.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The genetic basis for cancer treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Whole-genome sequencing and cancer therapy: is too much ever enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Leukemia in twins: lessons in natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Genetic variegation of clonal architecture and propagating cells in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Intratumor heterogeneity: evolution through space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Clonal evolution in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells: approaches to isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells: liquid biopsy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells as prognostic markers in neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The identification and characterization of breast cancer CTCs competent for brain metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

mRNA-Seq whole-transcriptome analysis of a single cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Epithelial-mesenchymal transition and cell cooperativity in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Malignant cells facilitate lung metastasis by bringing their own soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Clinical relevance and biology of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolation of rare cells from cell mixtures by dielectrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Single-cell paired-end genome sequencing reveals structural variation per cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Comprehensive human genome amplification using multiple displacement amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Combined transcriptome and genome analysis of single micrometastatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Correlation between circulating cancer cells and incidence of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The effect of intravenous fluids on the development on experimental tumour metastases: their effect on tumour cell aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Quantitative relationship between volume of tumour cell units and their intravascular survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Early epochal maps of two different cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

EMT: when epithelial cells decide to become mesenchymal-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Reciprocal regulation of RhoA and RhoC characterizes the EMT and identifies RhoC as a prognostic marker of colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Cisplatin influences acquisition of resistance to molecular-targeted agents through epithelial-mesenchymal transition-like changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells as a window on metastasis biology in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

A perspective on cancer cell metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug Therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Persistent E-cadherin expression in inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Haematogenous dissemination of cells from human renal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Identification and characterization of circulating prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumour cells: their utility in cancer management and predicting outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells as therapy-related biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Prognostic impact of circulating tumor cells in patients with small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Tissue-based approaches to study pharmacodynamic endpoints in early phase oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Liquid biopsy: monitoring cancer-genetics in the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumour cells and cell-free DNA as tools for managing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

External quality assurance of circulating tumor cell enumeration using the CellSearch® system: A feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Biomarker-driven patient selection for early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Tumor dissemination: an EMT affair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Isolation and retrieval of circulating tumor cells using centrifugal forces.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Imaging cytometry for counting circulating tumor cells: comparative analysis of the CellSearch vs ImageStream systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

The metastasizability of tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Aggregated colon cancer cells have a higher metastatic efficiency in the liver compared with nonaggregated cells: an experimental study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Evidence for the clonal origin of spontaneous metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Carcinoma of the colon and rectum: Circulating malignant cells and five-year survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Characterization of circulating tumor cells by fluorescence in situ hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2013.253

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system

31 March 2020

1 reference

12 December 2020

An electron microscopic study of pulmonary tumor emboli from transplantable Morris hepatoma 5123.

1 reference

12 December 2020

Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells.

1 reference

12 December 2020

Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer

1 reference

12 December 2020

Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation

1 reference

12 December 2020

Relationship between size and distribution of spontaneous metastases and three sizes of intravenously injected particles of VX2 carcinoma

1 reference

12 December 2020

Isolation of prostate-derived single cells and cell clusters from human peripheral blood

1 reference

12 December 2020

Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell

1 reference

12 December 2020

Immune stimulation-inhibition of experimental cancer metastasis

1 reference

12 December 2020

Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine

1 reference

12 December 2020

An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma

1 reference

12 December 2020

Identification of a cancer stem cell in human brain tumors

1 reference

12 December 2020

Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients

1 reference

12 December 2020

A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire.

1 reference

12 December 2020

The significance of hematogenous tumor cell clumps in the metastatic process

1 reference

12 December 2020

Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro.

1 reference

12 December 2020

Vimentin expression is associated with decreased survival in gastric cancer

1 reference

12 December 2020

Tumor heterogeneity and the biology of cancer invasion and metastasis

1 reference

12 December 2020

10.1038/NRCLINONC.2013.253

Identifiers

DOI

1 reference

30 August 2017

1 reference